High-density lipoprotein subfractions: current views and clinical practice applications
Authors:
- 1 July 2014
- journal article
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 25 (7) , 329-336
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- High-Density Lipoprotein Cholesterol and Particle Concentrations, Carotid Atherosclerosis, and Coronary EventsJACC, 2012
- Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL CholesterolJAMA, 2011
- Peroxisome Proliferator-Activated Receptor-α Activation Promotes Macrophage Reverse Cholesterol Transport Through a Liver X Receptor–Dependent PathwayArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and AtherosclerosisNew England Journal of Medicine, 2011
- Biological, clinical and population relevance of 95 loci for blood lipidsNature, 2010
- Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosisAtherosclerosis, 2010
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysisThe Lancet, 2010
- HDL in humans with cardiovascular disease exhibits a proteomic signatureClinica Chimica Acta, 2010
- Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolismJournal of Lipid Research, 2009
- Distinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serumProceedings of the National Academy of Sciences, 2007